Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From Isolation to Application: Utilising Phage‐Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug‐Resistant Enterococcus faecalis

1 Jan 2025

Abstract excerpt

Enterococcus species, natural inhabitants of the human gut, have become major causes of life-threatening bloodstream infections (BSIs) and the third most frequent cause of hospital-acquired bacteremia. The rise of high-level gentamicin resistance (HLGR) in enterococcal isolates complicates treatment and revives bacteriophage therapy. This study isolated and identified forty E. faecalis clinical isolates, with 30%...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Microbial infections and disease research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39801028
DOI: 10.1111/1751-7915.70075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From Isolation to Application: Utilising Phage‐Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug‐Resistant Enterococcus faecalisPMID 39801028Read ↗

Characterization of an Enterococcus faecalis bacteriophage SFQ1 as a potential therapeutic agentSemantic proximity Read ↗

Characterization of phage vB_EfS_C1 and investigation of antibacterial and antibiofilm properties against vancomycin-susceptible and vancomycin-resistant Enterococcus faeciumSemantic proximity Read ↗

Isolation of a lytic bacteriophage vB_EfaS_PHB08 and its endolysin lys08 against Enterococcus faecalis biofilmSemantic proximity Read ↗

<i>In-vitro</i> resensitization of multidrug resistant clinical isolates of <i>Enterococcus faecium</i> and <i>faecalis</i> through phage-antibiotic synergySemantic proximity Read ↗

Temperate phage-antibiotic synergy is widespread, but varies by phage, host, and antibiotic pairingSemantic proximity Read ↗

Phage–Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against Enterococcus faecalisSemantic proximity Read ↗

Large scale phage-antibiotic combination studies reveal key combinations for urinary tract infection and urosepsis treatmentsSemantic proximity Read ↗

Large scale phage-antibiotic combination studies reveal key combinations for urinary tract infection and urosepsis treatmentsSemantic proximity Read ↗

Comparison of Enterococcus faecalis Biofilm Removal Efficiency among Bacteriophage PBEF129, Its Endolysin, and CefotaximeSemantic proximity Read ↗

Bacteriophages of <i>Klebsiella</i> spp., their diversity and potential therapeutic usesSemantic proximity Read ↗

Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic CombinationsSemantic proximity Read ↗

Phage-antibiotic synergy reduces Burkholderia cenocepacia populationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.